Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-10T05:38:40.758Z Has data issue: false hasContentIssue false

Intratympanic gentamicin for Ménière’s disease; a survey of current UK practice

Published online by Cambridge University Press:  08 March 2006

R. J. Obholzer
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, St Bartholomew’s and The Royal London Hospitals, London, UK.
M. J. Wareing
Affiliation:
Department of Otolaryngology – Head and Neck Surgery, St Bartholomew’s and The Royal London Hospitals, London, UK.

Abstract

Intratympanic gentamicin is increasingly used in the treatment of Ménière’s disease. Many protocols have been published for its use, but there is little difference in outcome between them. The goal of the study was therefore to assess current UK practice in the use of intratympanic gentamicin.

A postal and e-mail survey of consultant ENT surgeons in the UK was conducted. Of 34 consultants who regularly used intratympanic gentamicin, 21 used a protocol based upon a single intratympanic dose of gentamicin via a needle through the tympanic membrane and repeated after at least a week. The remaining 13 used either a regime of more frequent administration or attempted a more complicated route of delivery in an effort to improve reliability and selectivity of action.

In the absence of evidence demonstrating benefit from regimens of increased complexity the majority of consultants are using the simplest possible protocol.

Type
Research Article
Copyright
© Royal Society of Medicine Press Limited 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)